Mohamed El Bousmaqui

Title: Innovations of Mohamed El Bousmaqui

Introduction

Mohamed El Bousmaqui is a notable inventor based in Aulnoy-lez-Valenciennes, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective NK-3 receptor antagonists. With a total of three patents to his name, his work has the potential to impact therapeutic treatments for various disorders.

Latest Patents

El Bousmaqui's latest patents include innovative compounds known as Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines. These compounds serve as selective NK-3 receptor antagonists and are designed for use in pharmaceutical compositions. The patents detail methods for their application in NK-3 receptor mediated disorders and describe a novel chiral synthesis of these compounds using N-sp3 protective groups. Additionally, the inventions provide intermediates that are essential for the synthesis of these compounds.

Career Highlights

Throughout his career, Mohamed El Bousmaqui has worked with prominent companies in the pharmaceutical industry, including Ogeda and Euroscreen. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

El Bousmaqui has collaborated with notable professionals in his field, including Hamid R. Hoveyda and Guillaume Dutheuil. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Mohamed El Bousmaqui is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in therapeutic treatments. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.